Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024
Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024
Truist Securities维持对Tenet Healthcare的买入,将目标股价上调至105美元,于2024年2月8日发布的报告
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $92 to $105.
Truist Securities分析师戴维·麦克唐纳维持Tenet Healthcare(纽约证券交易所代码:THC)的买入并将目标股价从92美元上调至105美元。